Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p73
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 73/191)
Character Range: 10334343–10348672

Patient must have had radiotherapy for this condition with incomplete resolution.
C6752               P6752          CN6752           Trametinib                                                                                                                                                                 Unresectable Stage III or Stage IV malignant melanoma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Compliance with Authority Required procedures - Streamlined Authority Code 6752
                                                                                                                                                                                                                               Continuing treatment
                                                                                                                                                                                                                               Patient must have previously been issued with an authority prescription for this drug; AND
                                                                                                                                                                                                                               Patient must be receiving PBS-subsidised dabrafenib concomitantly for this condition; AND
                                                                                                                                                                                                                               Patient must have stable or responding disease.
C6773               P6773          CN6773           Alprazolam                                                                                                                                                                 Panic disorder                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Compliance with Authority Required procedures
                                                                                                                                                                                                                               The treatment must be for use when other treatments have failed.  or
                                                                                                                                                                                                                               The treatment must be for use when other treatments are inappropriate.
C6786               P6786          CN6786           Electrolyte replacement, oral                                                                                                                                              Rehydration in intestinal failure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Compliance with Authority Required procedures

C6787               P6787          CN6787           Bromocriptine                                                                                                                                                              Pathological hyperprolactinaemia
                                                                                                                                                                                                                               Patient must be one in whom surgery is not indicated.
C6803               P6803          CN6803           Cobimetinib                                                                                                                                                                Unresectable Stage III or Stage IV malignant melanoma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Compliance with Authority Required procedures - Streamlined Authority Code 6803
                                                                                                                                                                                                                               Continuing treatment
                                                                                                                                                                                                                               Patient must have previously been issued with an authority prescription for this drug; AND
                                                                                                                                                                                                                               Patient must be receiving PBS-subsidised vemurafenib concomitantly for this condition; AND
                                                                                                                                                                                                                               Patient must have stable or responding disease.
C6809               P6809          CN6809           Calcipotriol with betamethasone                                                                                                                                            Chronic stable plaque type psoriasis vulgaris
                                                                                                                                                                                                                               The condition must be inadequately controlled by potent topical corticosteroid monotherapy.
C6812               P6812          CN6812           Ferrous fumarate                                                                                                                                                           For treatment of a patient identifying as Aboriginal or Torres Strait Islander

                                                    Ferrous fumarate with folic acid

C6815               P6815          CN6815           Salbutamol                                                                                                                                                                 Asthma
                                                                                                                                                                                                                               Patient must be unable to use this drug delivered from an oral pressurised inhalation device via a spacer.
C6825               P6825          CN6825           Salbutamol                                                                                                                                                                 Chronic obstructive pulmonary disease (COPD)
                                                                                                                                                                                                                               Patient must be unable to use this drug delivered from an oral pressurised inhalation device via a spacer.
C6847               P6847          CN6847           Alemtuzumab                                                                                                                                                                Multiple sclerosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 6847
                                                                                                                                                                                                                               Continuing treatment
                                                                                                                                                                                                                               Patient must have previously received PBS-subsidised treatment with this drug for this condition; AND
                                                                                                                                                                                                                               Patient must not show continuing progression of disability while on treatment with this drug; AND
                                                                                                                                                                                                                               Patient must not receive more than one PBS-subsidised treatment per year; AND
                                                                                                                                                                                                                               The treatment must be the sole PBS-subsidised disease modifying therapy for this condition; AND
                                                                                                                                                                                                                               Patient must have demonstrated compliance with, and an ability to tolerate this therapy; AND
                                                                                                                                                                                                                               Must be treated by a neurologist.
C6852               P6852          CN6852           Fosaprepitant                                                                                                                                                              Nausea and vomiting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures - Streamlined Authority Code 6852
                                                                                                                                                                                                                               The condition must be associated with cytotoxic chemotherapy being used to treat malignancy; AND
                                                                                                                                                                                                                               The treatment must be in combination with a 5-hydroxytryptamine receptor (5HT3) antagonist and dexamethasone on day 1 of a chemotherapy cycle; AND
                                                                                                                                                                                                                               Patient must be scheduled to be administered a chemotherapy regimen that includes either carboplatin or oxaliplatin.
                                                                                                                                                                                                                               No more than 1 vial